Women's Health

 

Bisphosphonate Use Associated with Increased Fracture Risk

September 16, 2020

Bisphosphonate use, especially for more than five years, is associated with an increased risk of atypical femoral fractures, but this risk falls considerably after discontinuation, according to a Nationwide Danish an analysis and review presented on September 13 at the American Society for Bone and Mineral Research (ASBMR) annual meeting which was held virtually.

Zoledronate As Booster Drug in Fight Against Osteoporosis

September 14, 2020

Some evidence shows the combination of teriparatide and denosumab, followed by a single dose of zoledronate, may be an effective strategy in the long-term management of high-risk fragility fractures.

High-Intensity Activity in Adolescence May Help Prevent Osteoporosis

September 14, 2020

Spending more time in high-intensity physical activity in early life may protect against osteoporosis in later life, and men are more successful at this than women, according to a study recently published in JAMA Network Open.

Calcium and Vitamin D First to Reduce Fracture Risk?

September 14, 2020

Drug therapy appears to be the first-line option for reducing fracture risk in osteoporosis, but it is not always feasible, and increasing calcium, vitamin D and protein intake may be a more practical option.

Q&A: Vitamin D and Bone Mineral Density

September 14, 2020

High-dose vitamin D supplementation compared with standard-dose vitamin D supplementation resulted in a greater loss of volumetric bone mineral density in women but not men, according to study data presented at the American Society for Bone and Mineral Research (ASBMR) annual meeting which is being held virtually.

Q&A: Anabolic Agents for Osteoporosis

September 14, 2020

Three months of treatment with the osteoporosis drug abaloparatide (Tymlos, Radius) has a robust effect on bone formation in postmenopausal women with osteoporosis, according to a study presented on Sept. 12 at the American Society for Bone and Mineral Research (ASBMR) annual meeting which is being held virtually.

Atypical Bone Fracture Risk Rises With Bisphosphonates

August 24, 2020

Atypical femur fracture risks are very low, but the risk rises with long-term use of bisphosphonate, study says.

Bisphosphonates Lower Fracture Risk, but Not Mortality

August 24, 2020

Mortality rates after a bone fracture can be as high as 45% in the first year of a break, and while bisphosphonates can lower the risk of recurring fractures, it doesn't appear to lower the risk of death.

Podcast: Are your patients well verse on vitamin D intake?

August 03, 2020

Managing vitamin D levels may not be as straightforward as it would seem. There are factors that should be considered that are not often communicated to patients. In today's edition of Overdrive, the Rheumatology Network podcast, we talk with Dr. Suzanne Jan de Beur of Johns Hopkins University School of Medicine. She serves as director of endocrinology at Johns Hopkins Bayview Medical Center and president-elect of the American Society for Bone and Mineral Research.

Oral Fluconazole Use in the First Trimester Linked to Musculoskeletal Malformations

May 27, 2020

Pregnant women who took fluconazole orally had a higher risk of giving birth to a baby with muscle and bone malformation, shows a new study published in The BMJ.

20 Key Takeaways From the Rheumatology Pregnancy Guidelines

February 28, 2020

Most women with rheumatic and musculoskeletal diseases will have successful pregnancies with the aid of medical planning, treatment and monitoring. These can be high risk pregnancies for both mother and child. The American College of Rheumatology recently issued treatment guidelines for the management of reproductive health in patients with rheumatic or musculoskeletal disease. Here are takeaways from the guidelines.

Treatment Guidelines Issued for Reproductive Health in Rheumatic and Musculoskeletal Diseases

February 25, 2020

New this week: The American College of Rheumatology has issued treatment guidelines for the management of reproductive health in rheumatic and musculoskeletal diseases. They include 12 ungraded good practice statements and 131 graded recommendations for all female patients considering becoming pregnant.

Probiotics Protect Against Lumbar Spine Bone Loss in Early Menopause

January 28, 2020

Probiotic supplementation using a mix of three Lactobacillus strains naturally occurring in the human gut microbiota protects against lumbar spine bone loss in healthy, early postmenopausal women, say researchers recently writing in The Lancet Rheumatology.

Cardiovascular Disease in Postmenopausal Women with Metabolic Syndrome

September 26, 2019

Postmenopausal women with early rheumatoid arthritis have a metabolic syndrome profile similar to men and should equally be considered high risk for the development of cardiovascular disease, according to Bindee Kuriya M.D, writing in the journal ACR Open Rheumatology.

Calcium Supplementation Doesn't Improve or Hurt Cardiovascular Health

September 23, 2019

Taking calcium supplements doesn't appear to worsen cardiovascular health in healthy postmenopausal women, according to a study presented at the American Society for Bone and Mineral Research annual meeting that took place over the weekend.

Knee Osteoarthritis Pain Intensity is Gender-Related

September 19, 2019

Levels of the biomarker urine C-telopeptide of cross-linked collagen type II (uCTX-II) are independently associated with radiographic severity and pain intensity in knee osteoarthritis, say researchers writing in Arthritis Research & Therapy this month.

Pregnancy Concerns Weigh Heavy on Female RA Patients

August 20, 2019

Women with rheumatoid arthritis are concerned with pregnancy and parenting issues and require more information from their doctors, say researchers writing in ACR Open Rheumatology this month.

Pitfalls Associated with Diagnosing Polymyalgia Rheumatica and Fibromyalgia in Young Obese Patients

July 30, 2019

Fibromyalgia and polymyalgia rheumatica are distinctly different, but in a case report described in the May 8 issue of the American Journal of Case Reports, Fawad Aslam, M.D., of Mayo Clinic in Arizona, and colleagues describe a confusing case of a 30-year-old woman.

Cumulative Estrogen may Predispose Women to Autoimmune Disease

July 11, 2019

Women who have primary Sjögren’s Syndrome also have decreased lifetime exposure to estrogen, a new study has determined.

Sjögren’s Risk in Women with Low Estrogen Levels

June 28, 2019

Women who have primary Sjögren’s Syndrome also have decreased lifetime exposure to estrogen, a new study finds.